Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online August 8, 2007
Diabetes 56:2732-2743, 2007
DOI: 10.2337/db07-0461
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0461v1
56/11/2732    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasavada, R. C.
Right arrow Articles by Garcia-Ocaña, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasavada, R. C.
Right arrow Articles by Garcia-Ocaña, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Kinase C-{zeta} Activation Markedly Enhances ß-Cell Proliferation

An Essential Role in Growth Factor–Mediated ß-Cell Mitogenesis

Rupangi C. Vasavada1, Lin Wang1, Yuichi Fujinaka1, Karen K. Takane1, Taylor C. Rosa1, Jose M.D. Mellado-Gil1, Peter A. Friedman2, and Adolfo Garcia-Ocaña1

1 Department of Medicine, Division of Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Address correspondence and reprint requests to Adolfo Garcia-Ocaña, PhD, Division of Endocrinology, University of Pittsburgh, 200 Lothrop St., BST-E1156, Pittsburgh, PA 15261. E-mail: ocana{at}dom.pitt.edu

Abbreviations: Adv-CA-PKC{zeta}, adenovirus containing the cDNA of constitutively active PKC{zeta}; Adv-KD-PKC{zeta}, adenovirus containing the cDNA of kinase-dead PKC{zeta}; Adv-LacZ, adenovirus containing the cDNA of ß-galactosidase; BrdU, 5-bromo-2'-deoxyuridine; DAG, diacylglycerol; DAPI, 4,6-diamidino-2-phenylindole; ERK, extracellular signal–regulated kinase; FBS, fetal bovine serum; GLP-1, glucagon-like peptide 1; HGF, hepatocyte growth factor; MOI, multiplicity of infection; PDK-1, phosphoinositide-dependent kinase 1; PI, phosphatidylinositol; PKC, protein kinase C; PTH1R, parathyroid hormone 1 receptor; PTHrP, parathyroid hormone–related protein; RIP, rat insulin II promoter; siRNA, small-interfering RNA

OBJECTIVE— Diabetes results from a deficiency of functional ß-cells. Previous studies have identified hepatocyte growth factor (HGF) and parathyroid hormone–related protein (PTHrP) as two potent ß-cell mitogens. The objective of this study is to determine 1) whether HGF and PTHrP have additive/synergistic effects on ß-cell growth and proliferation; 2) the signaling pathways through which these growth factors mediate ß-cell mitogenesis; and 3) whether activation of this/these signaling pathway(s) enhances human ß-cell replication.

RESEARCH DESIGN AND METHODS— We generated and phenotypically analyzed doubly transgenic mice overexpressing PTHrP and HGF in the ß-cell. INS-1 and primary mouse and human islet cells were used to identify mitogenic signaling pathways activated by HGF and/or PTHrP.

RESULTS— Combined overexpression of HGF and PTHrP in the ß-cell of doubly transgenic mice did not result in additive/synergistic effects on ß-cell growth and proliferation, suggesting potential cross-talk between signaling pathways activated by both growth factors. Examination of these signaling pathways in INS-1 cells revealed atypical protein kinase C (PKC) as a novel intracellular target activated by both HGF and PTHrP in ß-cells. Knockdown of PKC{zeta}, but not PKC{iota}/{lambda}, expression using specific small-interfering RNAs blocked growth factor–induced INS-1 cell proliferation. Furthermore, adenovirus-mediated delivery of kinase-dead PKC{zeta} completely inhibited ß-cell proliferation in primary islet cells overexpressing PTHrP and/or HGF. Finally, adenovirus-mediated delivery of constitutively active PKC{zeta} in mouse and human primary islet cells significantly enhanced ß-cell proliferation.

CONCLUSIONS— PKC{zeta} is essential for PTHrP- and HGF-induced ß-cell proliferation. PKC{zeta} activation could be useful in therapeutic strategies for expanding ß-cell mass in vitro and in vivo.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
N. M. Fiaschi-Taesch, D. M. Berman, B. M. Sicari, K. K. Takane, A. Garcia-Ocana, C. Ricordi, N. S. Kenyon, and A. F. Stewart
Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets
Diabetes, October 1, 2008; 57(10): 2745 - 2754.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Schmitz-Peiffer and T. J. Biden
Protein Kinase C Function in Muscle, Liver, and {beta}-Cells and Its Therapeutic Implications for Type 2 Diabetes
Diabetes, July 1, 2008; 57(7): 1774 - 1783.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.